IRONWOOD PHARMACEUTICALS, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value of $49.70 million as of 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue · last filed 2018-05-04
- 2018-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $49.70M.
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $95.70M.
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $37.80M.
- 2017-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $90.80M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value |
|---|---|
| 2018-03-31 | $49.70M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $95.70M 10-Q · filed 2018-05-04 |
| 2017-09-30 | $37.80M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $90.80M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $155.30M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $111.30M 10-K · filed 2018-02-22 |
| 2016-09-30 | $5.20M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $4.00M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $50.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $167.60M 10-K · filed 2017-02-22 |
| 2015-09-30 | $41.80M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $73.80M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $56.80M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $101.90M 10-K · filed 2016-02-19 |
| 2014-09-30 | $42.40M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $85.50M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $80.40M 10-Q · filed 2014-04-29 |
| 2013-12-31 | $38.70M 10-K · filed 2015-02-18 |
| 2013-09-30 | $4.20M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $30.90M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $40.10M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $3.00M 10-K · filed 2014-02-07 |
| 2012-09-30 | $16.80M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $42.60M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $19.80M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $35.50M 10-K · filed 2013-02-21 |
| 2010-12-31 | $94.70M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |